Using the similarity factor f2 in practice: A critical revision and suggestions for its standard error estimation

Chemometrics and Intelligent Laboratory Systems

Volumn 99, Issue 1, 2009, Pages 49-56

  Ocaña, Jordi ^a   Frutos, Gloria ^b   Sánchez O, Pilar ^c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

Bias correction; Bootstrap; Consumer risk; Jackknife; Producer risk; Simulation

Indexed keywords

ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; BOOTSTRAPPING; CONFIDENCE INTERVAL; DATA ANALYSIS; DISSOLUTION; PRIORITY JOURNAL; RELIABILITY; SIMULATION; STANDARDIZATION; STATISTICAL SIGNIFICANCE; VALIDITY;

EID: 70349814178     PISSN: 01697439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemolab.2009.07.010     Document Type: Article

References (29)

1. Tsong Y., Sathe P.M., and Shah V.P. In vitro dissolution profile comparison. In: Chow S.C. (Ed). Encyclopedia of Biopharmaceutical Statistics. Second Edition (2003), Marcel Dekker, Inc., New York 456-462
2. Moore J.W., and Flanner H.H. Mathematical comparison of dissolution profiles. Pharm. Technol. 20 (1996) 64-74
3. Freitag G. Guidelines on dissolution profile comparison. Drug Inf. J. 35 (2001) 865-874
4. FDA/CDER. Guidance for Industry. Immediate Release Solid Oral Dosage Forms. Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls, In Vitro Dissolution Testing, and In Vivo Bioequivalence Documentation. US Food and Drug Administration Web Site. Available at http://www.fda.gov/cder/guidance/cmc5.pdf (accessed 3/19/2009).
5. FDA/CDER. Guidance for Industry: Waiver of in vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System. US Food and Drug Administration Web Site. Available at http://www.fda.gov/cder/guidance/3618fnl.pdf (accessed 3/19/2009).
6. EMEA CPMP/QWP/604/96. Note for Guidance on Quality of Modified Release Products: A: Oral Dosage Forms B: Transdermal Dosage Forms. European Agency for the Evaluation of Medical Products Web Site. Available at http://www.emea.europa.eu/pdfs/human/qwp/060496en.pdf (accessed 3/19/2009).
7. EMEA CPMP/EWP/QWP/1401/98. Note for Guidance on the Investigation of Bioavailability and Bioequivalence. European Agency for the Evaluation of Medical Products Web Site. Available at http://www.emea.europa.eu/pdfs/human/qwp/140198en.pdf (accessed 3/19/2009).
8. Philip A.K., and Pathak K. Osmotic flow through asymmetric membrane: a means for controlled delivery of drugs with varying solubility. AAPS PharmSciTech 7 3 (2006) 10.1208/pt070356 Article 56
9. Lu C., Lu Y., Chen J., Zhang W., and Wu W. Synchronized and sustained release of multiple components in silymarin from erodible monostearate matrix system. Eur. J. Pharm. Biopharm. 66 (2007) 210-219
10. Dave B.S., Amin A.F., and Patel M.M. Gastroretentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation. AAPS PharmSciTech 5 2 (2004) article 34
11. Patel D.M., Patel N.M., Patel V.F., and Bhatt D.A. Floating granules of ranitidine hydrochloride-gelucire 43/01: formulation optimization using factorial design. AAPS PharmSciTech 8 2 (2007) 10.1208/pt0802030 Article 30
12. Wang M.T., Tsai F.H., and Wang D.P. Formulation optimization of controlled-release pellets of metoclopramide hydrochloride using dissolution fit factor approach. Drug Dev. Ind. Pharm. 26 (2001) 577-581
13. Wilson W.I., Peng Y., and Augsburger L.L. Comparison of statistical analysis and bayesian networks in the evaluation of dissolution performance of BCS class II model drugs. J. Pharm. Sci. 94 (2005) 2764-2776
14. Li J., Yang L., Ferguson S.M., Hudson T.J., Watanabe S., Katsuma M., and Fix J.A. In vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODES™) in multi-pH media using United States Pharmacopeia apparatus II and III. AAPS PharmSciTech 3 4 (2002) article 33
15. Ibrić S., Jovanović M., Djurić Z., Parojčić J., Petrović S., Solomun L., and Stupar B. Artificial neural networks in the modeling and optimization of aspirin extended release tablets with eudragit L 100 as matrix substance. AAPS PharmSciTech 4 1 (2003) article 9
16. Fernández-Arévalo M., Alvarez-Fuentes J., Iruin A., and Holgado M.A. In vitro evaluation of a morphine polymeric complex: flowability behavior and dissolution study. AAPS PharmSciTech 5 3 (2004) article 39
17. Eddington N.D., Rekhi G.S., Lesko L.J., and Augsburger L.L. Scale-up effects on dissolution and bioavailability of propranolol hydrochloride and metoprolol tartrate tablet formulations. AAPS PharmSciTech 1 2 (2000) article 14
18. Cao Q.-R., Choi Y.-W., Cui J.-H., and Lee B.-J. Formulation, release characteristics and biovailability of novel monolothic hydroxypropylmethylcellulose matrix tablets containing acetaminophen. J. Control. Release 108 (2005) 351-361
19. Gambhire M.N., Ambade K.W., Kurmi S.D., Kadam V.J., and Jadhav K.R. Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride. AAPS PharmSciTech 8 3 (2007) 10.1208/pt0803073 article 73
20. Flanner H.H., Vesey C.F., and Loehe L.R. Dissolution fit factors as response variables in statistically designed experiments. Dissolution Technol 8 (2001) 13-18
21. 2 as a criterion for assessment of similarity between dissolution profiles. Drug Inf. J. 31 (1997) 1255-1271
22. 2. Pharm. Res. 15 (1999) 889-895
23. Ma M.C., Wang B.B.C., Liu J.P., and Tsong Y. Assessment of similarity between dissolution profiles. J. Biopharm. Stat. 10 (2000) 229-249
24. Frutos G., and Ruiz de Villa M.C. Nonlinear mixed-effects model for the dissolution assays of drugs. J. Control. Release 94 (2004) 381-389
25. C.V. Pabón, Desarrollo galénico de matrices de poliamida 12 para la liberación controlada de motoclopramida clorhidrato [thesis]. Madrid, Spain: Facultad de Farmacia, Universidad Complutense de Madrid (1995).
26. R Development Core Team, R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org. (2007).
27. USP31-NF26. United States Pharmacopeial Convention, Inc., Rocville, Chapter<711>, (2007).
28. 2 in comparison of dissolution profiles. Dissolution Technol. 9 (2002) 18-22
29. Gohel M.C., Sarvaiya K.G., Mehta N.R., Soni C.D., Vyas V.U., and Dave R.K. Assessment of similarity factor using different weighting approaches. Dissolution Technol. 12 (2005) 22-27